Cargando…

A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol

Despite cannabidiol (CBD) having numerous cardiovascular effects in vitro, its haemodynamic effects in vivo are unclear. Nonetheless, the clinical use of CBD (Epidiolex) is becoming more widespread. The aim of this systematic review was to establish whether CBD is associated with changes in haemodyn...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultan, Salahaden R., Millar, Sophie A., England, Timothy J., O'Sullivan, Saoirse E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323388/
https://www.ncbi.nlm.nih.gov/pubmed/28286481
http://dx.doi.org/10.3389/fphar.2017.00081
_version_ 1782510012679061504
author Sultan, Salahaden R.
Millar, Sophie A.
England, Timothy J.
O'Sullivan, Saoirse E.
author_facet Sultan, Salahaden R.
Millar, Sophie A.
England, Timothy J.
O'Sullivan, Saoirse E.
author_sort Sultan, Salahaden R.
collection PubMed
description Despite cannabidiol (CBD) having numerous cardiovascular effects in vitro, its haemodynamic effects in vivo are unclear. Nonetheless, the clinical use of CBD (Epidiolex) is becoming more widespread. The aim of this systematic review was to establish whether CBD is associated with changes in haemodynamics in vivo. Twenty-five studies that assessed the haemodynamic effects of CBD (from PubMed, Medline and EMBASE) were systematically reviewed and meta-analyzed. Data on blood pressure (BP), heart rate (HR), and blood flow (BF) were extracted and analyzed using random effects models. Twenty-two publications assessed BP and HR among 6 species (BP n = 344 and HR n = 395), and 5 publications assessed BF in 3 species (n = 56) after acute dosing of CBD. Chronic dosing was assessed in 4 publications in 3 species (total subjects BP, n = 6; HR, n = 27; BF, n = 3). Acute CBD dosing had no effect on BP or HR under control conditions. Similarly, chronic dosing with CBD had no effect on HR. In models of stress, acute CBD administration significantly reduced the increase in BP and HR induced by stress (BP, mean difference (MD) −3.54, 95% CI −5.19, −1.9, p < 0.0001; HR, MD −16.23, 95% CI −26.44, −6.02, p = 0.002). In mouse models of stroke, CBD significantly increased cerebral blood flow (CBF, standardized mean difference (SMD) 1.62, 95% CI 0.41, 2.83, p = 0.009). Heterogeneity among the studies was present, there was no publication bias except in HR of control and stressful conditions after acute CBD dosing, and median study quality was 5 out of 9 (ranging from 1 to 8). From the limited data available, we conclude that acute and chronic administration of CBD had no effect on BP or HR under control conditions, but reduces BP and HR in stressful conditions, and increases cerebral blood flow (CBF) in mouse models of stroke. Further studies are required to fully understand the potential haemodynamic effects of CBD in humans under normal and pathological conditions.
format Online
Article
Text
id pubmed-5323388
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53233882017-03-10 A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol Sultan, Salahaden R. Millar, Sophie A. England, Timothy J. O'Sullivan, Saoirse E. Front Pharmacol Pharmacology Despite cannabidiol (CBD) having numerous cardiovascular effects in vitro, its haemodynamic effects in vivo are unclear. Nonetheless, the clinical use of CBD (Epidiolex) is becoming more widespread. The aim of this systematic review was to establish whether CBD is associated with changes in haemodynamics in vivo. Twenty-five studies that assessed the haemodynamic effects of CBD (from PubMed, Medline and EMBASE) were systematically reviewed and meta-analyzed. Data on blood pressure (BP), heart rate (HR), and blood flow (BF) were extracted and analyzed using random effects models. Twenty-two publications assessed BP and HR among 6 species (BP n = 344 and HR n = 395), and 5 publications assessed BF in 3 species (n = 56) after acute dosing of CBD. Chronic dosing was assessed in 4 publications in 3 species (total subjects BP, n = 6; HR, n = 27; BF, n = 3). Acute CBD dosing had no effect on BP or HR under control conditions. Similarly, chronic dosing with CBD had no effect on HR. In models of stress, acute CBD administration significantly reduced the increase in BP and HR induced by stress (BP, mean difference (MD) −3.54, 95% CI −5.19, −1.9, p < 0.0001; HR, MD −16.23, 95% CI −26.44, −6.02, p = 0.002). In mouse models of stroke, CBD significantly increased cerebral blood flow (CBF, standardized mean difference (SMD) 1.62, 95% CI 0.41, 2.83, p = 0.009). Heterogeneity among the studies was present, there was no publication bias except in HR of control and stressful conditions after acute CBD dosing, and median study quality was 5 out of 9 (ranging from 1 to 8). From the limited data available, we conclude that acute and chronic administration of CBD had no effect on BP or HR under control conditions, but reduces BP and HR in stressful conditions, and increases cerebral blood flow (CBF) in mouse models of stroke. Further studies are required to fully understand the potential haemodynamic effects of CBD in humans under normal and pathological conditions. Frontiers Media S.A. 2017-02-24 /pmc/articles/PMC5323388/ /pubmed/28286481 http://dx.doi.org/10.3389/fphar.2017.00081 Text en Copyright © 2017 Sultan, Millar, England and O'Sullivan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Sultan, Salahaden R.
Millar, Sophie A.
England, Timothy J.
O'Sullivan, Saoirse E.
A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
title A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
title_full A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
title_fullStr A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
title_full_unstemmed A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
title_short A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
title_sort systematic review and meta-analysis of the haemodynamic effects of cannabidiol
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323388/
https://www.ncbi.nlm.nih.gov/pubmed/28286481
http://dx.doi.org/10.3389/fphar.2017.00081
work_keys_str_mv AT sultansalahadenr asystematicreviewandmetaanalysisofthehaemodynamiceffectsofcannabidiol
AT millarsophiea asystematicreviewandmetaanalysisofthehaemodynamiceffectsofcannabidiol
AT englandtimothyj asystematicreviewandmetaanalysisofthehaemodynamiceffectsofcannabidiol
AT osullivansaoirsee asystematicreviewandmetaanalysisofthehaemodynamiceffectsofcannabidiol
AT sultansalahadenr systematicreviewandmetaanalysisofthehaemodynamiceffectsofcannabidiol
AT millarsophiea systematicreviewandmetaanalysisofthehaemodynamiceffectsofcannabidiol
AT englandtimothyj systematicreviewandmetaanalysisofthehaemodynamiceffectsofcannabidiol
AT osullivansaoirsee systematicreviewandmetaanalysisofthehaemodynamiceffectsofcannabidiol